Advances in Treatment of Waldenström Macroglobulinemia

被引：0
|
作者：
Eric Durot
Cécile Tomowiak
机构：
[1] CHU de Reims Et UFR Médecine,Hématologie Clinique
[2] CHU de Poitiers,Service d’Onco
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Waldenström macroglobulinemia; mutation; Chemoimmunotherapy; BTK inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1375 / 1386
页数：11
相关论文
共 50 条
  • [1] Advances in Treatment of Waldenström Macroglobulinemia
    Durot, Eric
    Tomowiak, Cecile
    CURRENT ONCOLOGY REPORTS, 2023, 25 (11) : 1375 - 1386
  • [2] BTK Inhibitors and Other Targeted Therapies in Waldenström Macroglobulinemia
    Chohan, Karan L.
    Kapoor, Prashant
    HEMATO, 2023, 4 (02): : 135 - 157
  • [3] Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia
    Tawfiq, Reema K.
    Abeykoon, Jithma P.
    Kapoor, Prashant
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2024, 19 (03) : 120 - 137
  • [4] Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy?
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cotilli, Giulia
    Cairoli, Roberto
    Tedeschi, Alessandra
    HEMATO, 2022, 3 (04): : 689 - 703
  • [5] Differential Diagnosis of Waldenstr?m?s Macroglobulinemia and Early Management: Perspectives from Clinical Practice
    Cingam, Shashank
    Sidana, Surbhi
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 107 - 117
  • [6] Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States
    Castillo, Jorge J.
    Kingsley, Edwin C.
    Narang, Mohit
    Yimer, Habte A.
    Dasanu, Constantin A.
    Melear, Jason M.
    Coleman, Morton
    Farber, Charles M.
    Shulman, Jonah
    Mantovani, Emily H.
    Zhang, Xiaowei
    Cohen, Aileen
    Huang, Jane
    EJHAEM, 2023, 4 (01): : 301 - 304
  • [7] WHIM Syndrome Caused by Waldenström’s Macroglobulinemia-Associated Mutation CXCR4L329fs
    Qian Liu
    Catherina Pan
    Lizbeeth Lopez
    Jiliang Gao
    Daniel Velez
    Sandra Anaya-O’Brien
    Jean Ulrick
    Patricia Littel
    John S. Corns
    Donald T. Ellenburg
    Harry L. Malech
    Philip M. Murphy
    David H. McDermott
    Journal of Clinical Immunology, 2016, 36 (4) : 397 - 405
  • [8] Detection of the MYD88L265P and CXCR4S338X mutations by cell-free DNA in Waldenström macroglobulinemia
    Yan-Yan Wu
    Ming-Nan Jia
    Hao Cai
    Yu Qiu
    Dao-Bin Zhou
    Jian Li
    Xin-Xin Cao
    Annals of Hematology, 2020, 99 : 1763 - 1769
  • [9] Zanubrutinib for the treatment of Waldenstrom Macroglobulinemia
    Lim, Kenneth J. C.
    Tam, Constantine S.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (12) : 1303 - 1310
  • [10] A Canadian Perspective on the Treatment of Waldenstrom Macroglobulinemia
    Kaedbey, Rayan
    Forward, Nicholas
    Sehn, Laurie H.
    Shafey, Mona
    Doucette, Sarah
    Chen, Christine, I
    CURRENT ONCOLOGY, 2022, 29 (10) : 7122 - 7139
12345